Ken Griffin Silk Road Medical Inc Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$16.95 - $27.04 $1.07 Million - $1.7 Million	-63,000 Reduced 63.96%	35,500 $959,000
Q1 2024 May 15, 2024	BUY	$11.38 - $19.03 $809,118 - $1.35 Million	71,100 Added 259.49%	98,500 $1.8 Million
Q4 2023 Feb 14, 2024	SELL	$6.29 - $15.72 $588,744 - $1.47 Million	-93,600 Reduced 77.36%	27,400 $336,000
Q3 2023 Nov 14, 2023	BUY	$14.99 - $32.65 $1.73 Million - $3.77 Million	115,500 Added 2100.0%	121,000 $1.81 Million
Q2 2023 Aug 14, 2023	SELL	$29.76 - $46.14 $455,328 - $705,942	-15,300 Reduced 73.56%	5,500 $178,000
Q1 2023 May 15, 2023	BUY	$38.09 - $57.79 $700,856 - $1.06 Million	18,400 Added 766.67%	20,800 $813,000
Q4 2022 Feb 14, 2023	SELL	$40.54 - $56.2 $178,376 - $247,280	-4,400 Reduced 64.71%	2,400 $126,000
Q3 2022 Nov 14, 2022	BUY	$36.98 - $49.2 $251,463 - $334,560	6,800 New	6,800 $306,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.